Search

everythinglearnresearchcommunity

for

Search:↓

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Pregnancy can cause skin changes and affect existing skin conditions, with limited treatment options due to the need for fetal safety.

Female relatives of PCOS patients have a higher chance of showing PCOS symptoms.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

Pregnancy can cause skin darkening, varicose veins, more sweating, hair growth, hair loss after birth, nail changes, and gum inflammation.

Most skin changes during pregnancy go away after giving birth.

Exposure to the hair loss drug finasteride during pregnancy can cause genital anomalies in male babies, but not in female babies. It's best to avoid this drug in women who could potentially become pregnant.

A mother's iron levels early in pregnancy can influence the DNA makeup of her child, potentially affecting the child's health.

Early surgical intervention and a multidisciplinary approach are crucial for managing complex cardio-obstetric patients.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Baby born healthy despite mom taking finasteride, but more research needed.

Pregnant women with isolated hypothyroxinemia face more health issues, so iodine and folic acid supplements are important before and during early pregnancy.

Testosterone reduces key molecules needed for early pregnancy in rats.

The document discusses how to diagnose and treat conditions like acne, excessive hair growth, and female pattern hair loss related to hormone imbalances.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.